Salvage therapy in cancer patients with hepatitis C without sustained virologic response after direct‐acting antivirals—A prospective study

BACKGROUND AND AIM: No information exists regarding direct‐acting antivirals (DAAs) salvage therapy for Hepatitis C (HCV)‐infected patients with any type of cancer. We prospectively evaluated the safety and efficacy (SVR12) of salvage therapy in these patients. METHODS: Patients who failed initial D...

Descripción completa

Detalles Bibliográficos
Autores principales: Pritchard, Haley, Jandhyala, Deeksha, Hosry, Jeff, Angelidakis, Georgios, Torres, Harrys A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273696/
https://www.ncbi.nlm.nih.gov/pubmed/32514467
http://dx.doi.org/10.1002/jgh3.12294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273696/
https://www.ncbi.nlm.nih.gov/pubmed/32514467
http://dx.doi.org/10.1002/jgh3.12294

Ejemplares similares